1. Hepatic volume was recorded by plethysmography in dogs anaesthetized with sodium pentobarbitone. Histamine infusions into the hepatic artery or portal vein increased hepatic volume while hepatic sympathetic nerve stimulation decreased the volume. Simultaneous nerve stimulation and histamine infusion decreased hepatic volume.2. The hepatic volume responses to histamine and nerve stimulation could not be explained on the basis of differences in the responses of the larger hepatic veins and the possibility of a histamine-sensitive sphincter at the junction of the hepatic vein with the inferior vena cava was excluded. Differences in the responses of the hepatic arterial bed contributed to but did not explain the different hepatic volume responses.3. It is suggested that histamine produced an intense and specific constriction of the sublobular veins with passive distension of post-sinusoidal venules, sinusoids and portal venules while hepatic nerve stimulation produced a uniform and generalized constriction of both pre- and post-sinusoidal vessels.4. Intravenous infusions of histamine produced a marked hypotension but small variable effects on hepatic volume. It is concluded that hepatic pooling is not the cause of the hypotension produced by intravenous histamine and that significant hepatic pooling will only be produced by mechanisms which release endogenous histamine within the liver.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1776557PMC
http://dx.doi.org/10.1111/j.1476-5381.1973.tb08326.xDOI Listing

Publication Analysis

Top Keywords

hepatic volume
24
nerve stimulation
16
hepatic
15
histamine hepatic
8
differences responses
8
histamine produced
8
hepatic pooling
8
volume
7
histamine
7
produced
5

Similar Publications

Non-Target Hemangioma Size Reduction After Bleomycin-Lipiodol Embolization of Primary Hepatic Hemangioma.

J Vasc Interv Radiol

January 2025

Inonu University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Malatya, Türkiye.

Purpose: To evaluate changes in non-target hepatic hemangiomas, which are neither subjected to embolization nor targeted for treatment, following selective bleomycin-lipiodol transarterial chemoembolization (TACE) of a giant hepatic hemangioma.

Materials And Methods: This single-center retrospective study included 24 patients with non-target hepatic hemangiomas distinct from primary giant hemangiomas treated with selective bleomycin-lipiodol TACE between 2009 and 2022. The size and volume of the lesions were assessed using computed tomography scans obtained before treatment, and at 6, 12 and 24 months.

View Article and Find Full Text PDF

Angiotensin II (Ang II) is the most active peptide hormone produced by the renin-angiotensin system (RAS). Genetic deletion of genes that ultimately restrict Ang II formation has been shown to result in marked anemia in mice. In this study, adult mice with a genetic deletion of the RAS precursor protein angiotensinogen (Agt-KO) were used.

View Article and Find Full Text PDF

Background: Liver malignancies present substantial challenges to surgeons due to the extensive hepatic resections required, frequently resulting in posthepatectomy liver failure. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) was designed to increase the resectable liver volume, yet it is associated with significant mortality and morbidity rates. Recently, minimally invasive techniques have been incorporated into ALPPS, with the potential to improve the procedure's safety profile whilst maintaining efficacy.

View Article and Find Full Text PDF

Objective: To assess the effects of inferior vena cava and/or hepatic vein (IVC±HV) venoplasty on liver volumetry and function in individuals with Budd Chiari syndrome (BCS) who present with ascites and at least one patent hepatic vein.

Methods: A retrospective analysis was conducted on the clinical data of 17 patients with BCS (6 males and 11 females, average age of 42.3 ± 11.

View Article and Find Full Text PDF

Evaluation of drug-drug interaction between rosuvastatin and tacrolimus and the risk of hepatic injury in rats.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Organ Transplantation, The Second Affiliated Hospital of Nanchang University, Minde Road No. 1, Nanchang, 330006, Jiangxi, China.

Multimorbidity, therapeutic complexity, and polypharmacy, which greatly increases the risk of drug-drug interactions (DDIs) and adverse medical outcomes, have become important and growing challenges in clinical practice. Statins are frequently prescribed to manage post-transplant dyslipidemia and reduce overall cardiovascular risk in solid organ transplant recipients. This study aimed to determine whether rosuvastatin has significant DDIs with tacrolimus (the first-line immunosuppressant) and to evaluate the risk of hepatotoxicity associated with concomitant therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!